Central acute D2 stimulation worsens bladder function in patients with mild Parkinson's disease

Journal of Urology

Volumn 175, Issue 1, 2006, Pages 202-206

  Brusa, Livia ^a,b   Petta, Filomena ^a   Pisani, Antonio ^a,b   Miano, Roberto ^a   Stanzione, Paolo ^a,b   Moschella, Vincenzo ^a   Galati, Salvatore ^a   Agrò, Enrico Finazzi ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Dopamine; Parkinson disease; Receptors; Urodynamics

Indexed keywords

CABERGOLINE; CARBIDOPA PLUS LEVODOPA; DOMPERIDONE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SULPIRIDE;

ADULT; AGED; ARTICLE; BLADDER CAPACITY; BLADDER DYSFUNCTION; BLADDER FUNCTION; BLADDER PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOMETRY; DETRUSOR MUSCLE; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG ACTIVITY; ELECTROMYOGRAPHY; FEMALE; HUMAN; INVOLUNTARY MOVEMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MICTURITION; MICTURITION REFLEX; MUSCLE CONTRACTILITY; OVERACTIVE BLADDER; PARKINSON DISEASE; PERINEUM; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SENSATION; SINGLE BLIND PROCEDURE; STIMULATION; URODYNAMICS;

DOMPERIDONE; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SULPIRIDE; URINARY BLADDER;

EID: 29144528873     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00058-3     Document Type: Article

References (20)

1. T. Hattori, K. Yasuda, K. Kita, K. Hirayama Voiding dysfunction in Parkinson's disease Jpn J Psychiatry Neurol 46 1992 181
2. A.J. Pavlakis, M.B. Siroky, I. Goldstein, R.J. Krane Neurourologic findings in Parkinson's disease J Urol 129 1983 80
3. B. Aranda, P. Cramer Effect of apomorphine and L-dopa on the parkinsonian bladder Neurourol Urodyn 12 1993 203
4. T.J. Christmas, P.A. Kempster, C.R. Chapple, J.P. Frankel, A.J. Lees, G.M. Stern Role of subcutaneous apomorphine in parkinsonian voiding dysfunction Lancet 2 1988 1451
5. F. Stocchi, A. Carbone, M. Inghilleri, A. Monge, S. Ruggieri, A. Berardelli Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy J Neurol Neurosurg Psychiatry 62 1997 507
6. S. Seki, Y. Igawa, K. Kaidoh, O. Ishizuka, O. Nishizawa, K.E. Andersson Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats Neurourol Urodyn 20 2001 105
7. N. Yoshimura, E. Mizuta, O. Yoshida, S. Kuno Therapeutic effects of dopamine D1/D2 receptors agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomologus monkeys J Pharmacol Exp Ther 286 1998 228
8. S.E. Daniel, A.J. Lees Parkinson's Disease Society Brain Bank, London overview and research J Neural Transm 39 suppl 1993 165
9. P. Abrams, L. Cardozo, M. Fall, D. Griffiths, P. Rosier, U. Ulmsten The standardisation of terminology of lower urinary tract function report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 2002 167
10. S. Fahn, R.L. Elton UPDRS Development Committee Unified Parkinson's disease rating scale S. Fahn C.D. Marsden D. Calne M. Golstein Recent Developments in Parkinson's Disease 1987 MacMillan Healthcare Information 2 Florham Park, New York 153 163 293-304
11. J.R. Bianchine, G.M. Shaw Clinical pharmacokinetics of levodopa in parkinson's disease Clin Pharmacokinet 1 1976 313
12. J. Bres, F. Bressolle Pharmacokinetics of sulpiride in humans after intravenous and intramuscular administrations J Pharm Sci 80 1991 1119
13. Y.C. Huang, J.L. Colaizzi, R.H. Bierman, R. Woestenborghs, J.J. Heykants Pharmacokinetics and dose proportionality of domperidone in healthy volunteers J Clin Pharmacol 26 1986 628
14. M. Stohrer, M. Goepel, A. Kondo, G. Kramer, H. Madersbacher, R. Millard International Continence Society Standardization Committee The standardization of terminology in neurogenic lower urinary tract dysfunction with suggestions for diagnostic procedures Neurourol Urodyn 18 1999 139
15. U. Sillen, A. Rubenson, K. Hjalmas Evidence for a central monoaminergic influence on urinary bladder control mechanism Scand J Urol Nephrol 13 1979 265
16. O. Ishizuka, A. Mattiasson, W.D. Steers, K.E. Andersson Effects of spinal alpha1-adrenoceptor antagonism on bladder activity induced by apomorphine in conscious rats with and without bladder outlet obstruction Neurourol Urodyn 16 1997 191
17. J. Ockrim, M.E. Laniado, B. Khoubehi, R. Renzetti, E. Finazzi Agro, S.S. Carter Variability of detrusor overactivity on repeated filling cystometry in men with urge symptoms comparison with spinal cord injury patients BJU Int 95 2005 587
18. M. Gerlach, K. Double, T. Arzberger, F. Leblhuber, T. Tatschner, P. Riederer Dopamine receptor agonists in current clinical use comparative dopamine receptor binding profiles defined in the human striatum J Neural Transm 110 2003 1119
19. C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, M.G. Caron Dopamine receptors from structure to function Physiol Rev 78 1998 189
20. T. Uchiyama, R. Sakakibara, T. Hattori, T. Yamanishi Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon Mov Disord 18 2003 573